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SIX YEARS OF CARDIAC DATABASE MANAGEMENT: THE IMPACT ON CLINICAL
PRACTICE
Furnaz S
Aga khan university and Hospital, Karachi, Pakistan
OBJECTIVES: To assess the impact of database development on clinical practice
and quality of care.METHODS:We chose the following aspects of patient care to be
included in the database form: pre-surgery patient condition and medications,
surgery information, recovery information, status of the patient atdischarge, 30-
days and 365-days post-surgery follow-up information.Information was collected
through structured questionnaire and entered into Microsoft Access software.
RESULTS: From January 2006–May 2011, there was 3418 open heart surgeries per-
formed. The overall 30-daymortality was 3.6%. Post-surgery morbidity was
21.5%which includes 3.6% reoperation for bleeding 0.6% neurological 0.7% dialysis
1.3% heart failure 0.3% septicemia 1.8% prolonged ventilation 8.6%multiorgan fail-
ure and 0.9% respiratory complications 1.7% cardiac arrest,1.1% deep sternal
wound infection 0.1% Followup at30-days patients alivewere 91.6% death 0.1% lost
to follow-up 3.6%and 365-daysshowed that alive 93.2% death2.1% lost to
followup,4.6%.CONCLUSIONS:Before thisdatabase, therewasnoway tomonitor the
risk factors, mortality and morbidity. Fortunately with the development of database,
pre operation risk factors, post-surgery mortality and morbidity rates could easily be
generated. Based on the prevalent risk factors coming up in our data we can help
prevent the cardiac disease. It also helped in controlling preventable post-surgery
complications. It also helps in identification of a gap inpatient knowledge regarding
theuseofwarfarin afterheart valve surgery anddeficiencies in laboratory capabilities,
both causing catastrophic complications. As a result, we modified our practice in an
effort to address these issues and reduce the complication rates after heart valve
surgery.Updatedandstringentlymaintaineddatabasehelps to identifydeficiencies in
practice and provides a direction for future improvement.
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DAY OF WEEK OF PROCEDURE AND 30-DAY IN-HOSPITAL MORTALITY FOR
ELECTIVE SURGERY
Jen MH
United BioSource Corporation, London, UK
OBJECTIVES: To investigate whether there is a relationship between the day of the
week patients undergo elective surgery and in-hospital death. METHODS: Retro-
spective analysis of secondary users service data on adjusted odds ratios for in-
hospital death within 30 days of procedure using logistic regression modelling.
Patients in acute and specialist English public hospitals undergoing elective sur-
gery over the financial years 2006 to 2008. RESULTS: There were 15,230 in-hospital
30-day deaths as a consequence of 4,197,761 all elective inpatient surgical admis-
sions (an overall crude mortality rate 3.6 per 1000). The overall adjusted odds of
death for all elective surgical procedures were 33% and respectively 90% higher if
the procedures were carried out on Friday or atWeekend compared to Monday (OR
1.33, 95% CI 1.26-1.41 and respectively OR 1.90, 95% CI 1.75-2.05). This equates to a
figure of over 700 excess annual deaths from elective surgery, based on applying
Monday mortality rates. CONCLUSIONS: The study suggests higher risk of death
for patients who have elective surgical procedures carried out closer to the week-
end, in particular on Friday. Further research is needed to understand the extent to
which the ‘weekday effect’ reflects differences in the quality of surgical care.
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PHARMACOTHERAPY AND ASSOCIATED OUTCOMES IN PEDIATRIC BIPOLAR
DEPRESSION
Bhowmik D1, Chen H1, Aparasu RR1, Rajan S1, Sherer JT1, Perez MO2
1University of Houston, Houston, TX, USA, 2Memorial Park Psychiatry, Houston, TX, USA
OBJECTIVES: To examine medication utilization pattern among Medicaid enrolled
children and adolescents with bipolar depression (BD). METHODS: Medicaid Ana-
lytic eXtract (MAX) data fromNewYork, Illinois, California, and Texas, from 2003 to
2007 was used in the analysis. Bipolar depression patients were identified from
inpatient and outpatient files by using ICD-9CM codes 296.5, 296.2, and 296.3. Uti-
lization of selective serotonin reuptake inhibitors (SSRI) and other antidepressants,
typical and atypical antipsychotics (SGA), and mood stabilizers (MS) (lithium, di-
valproex, oxcarbazepine etc) following a bipolar depression diagnosis was investi-
gated. Prevalence of significant outcomes of the disease, namely depressive (ICD-
9CM: 296.5, 296.2, 296.3) and manic (ICD-9CM: 296.0, 296.1, 296.4, 296.81) switch,
and suicidality (ICD-9CM: E950-E958, V62.84) were also measured after initiation of
pharmacotherapy treatment in the BD cohort. Descriptive analysis using SAS 9.2
was conducted to achieve the study objective. RESULTS: From descriptive analysis
23,113 children and adolescents aged 6-18 years and having a bipolar depression
diagnosis were identified. The most commonly used psychotropic drugs following
bipolar depression were SGA (76.45%), Mood stabilizer (66.05%), SSRI (48.71%), and
other antidepressants (35.58%). The most commonly used psychotropic combina-
tions were SGA-MS (40.40%), SGA-SSRI (12.20%), and SSRI-MS (6.04%). Suicidality
was revealed to be a rare outcome in patient cohort, with frequency of 133 (0.82%)
from outpatient file. Incidence of relapse tomania within 6 weeks of pharmacolog-
ical treatment in the patient cohort came out to be 27 (0.17%) from hospital visits
and 809 (5.01%) from office visits. Relapse to depression episode anytime post
pharmacotherapy was suggested to be common, with 692 (4.28%) inpatient and
11,380 (70.46%) outpatient visitors. CONCLUSIONS: Given current treatment guide-
line for pediatric bipolar disorder does not have any recommendation for bipolar de-
pression, future study is necessary to examine comparative effectiveness of existing
pharmacotherapies used in children and adolescents with bipolar depression.
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EVALUATING OUTCOMES FROM PRENATAL ANTIDEPRESSANT EXPOSURE: A
META-ANALYTIC REVIEW
Shen X, Raisch DW
University of New Mexico College of Pharmacy, Albuquerque, NM, USA
OBJECTIVES: To summarize the literature regarding pregnancy/birth/child devel-
opment outcomes of prenatal antidepressant exposure (PAE). METHODS: A Med-
line search was conducted up to October, 2011, restricted to English and human
literature. The MeSH term “antidepressive agents”, was combined with MeSH
terms for spontaneous abortion(SA), preterm birth(PB), birth weight(BW), small for
gestational age(SGA), or poor child development(PCD). We also searched articles
from reference lists of reviews and included studies. We limited the review to
studies with data analysis focusing on the impact of PAE on the outcomes listed
above. Cochran’s Q statistic was used to test the heterogeneity of the results of
included studies for each outcome.When heterogeneitywas absent, a fixed-effects
model was used to pool the effect estimates. Otherwise, meta-regression was per-
formed to explore the reasons for the observed heterogeneity. Meta-regression is a
regression analysis in which each study is a unit of observation and the effect
estimate is regressed on study characteristics. In this review, study characteristics
including antidepressant class, type of source population, adjustment formaternal
depression, exposure definition, duration and timing, and adjustment for more
than three covariates were examined. RESULTS: Thirty-three studies were in-
cluded (18 on PB, 9 on SA, 19 on BW). SGA and PCDwere excluded fromanalysis due
to the limited number of studies(n6). The test of heterogeneity was significant for
PB andmeta-regression showed that adjusting for more than three covariates was
significantly associated with the reported odds ratio(p0.02). The pooled odds ra-
tio(POR) for PB was 1.39 (95% confidence interval (CI)1.27-1.52) for studies with 3
covariates versus 1.82(95% CI1.43-2.29) for other studies. The POR for SA was
1.63(95% CI1.31-2.04) and the pooled difference in BW between the exposed and
the unexposed was -23.6(95% CI-50.1, 2.9) gram. CONCLUSIONS: The PORs
showed that PAE was associated with PB and SA, but not BW.
PMH3
ACNE DRUG THERAPY AND THE DEVELOPMENT OF COMORBID MAJOR
DEPRESSIVE DISORDER IN THE UNITED STATES
Lin HC1, Clodfelter RP1, Lee CH2, Balkrishnan R2, Feldman SR3
1Indiana Univeresity, Bloomington, IN, USA, 2University of Michigan, Ann Arbor, MI, USA,
3Wake Forest University, Winston-Salem, NC, USA
OBJECTIVES: Dermatological disorders are associated with secondary psychiatric
illnesses. In particular, acne carries an increased risk of developing major depres-
sive disorder (MDD) and other psychological comorbidities. The association be-
tween acne drug therapy and the incidence of secondary psychiatric disorders,
however, remains unclear. This study evaluated the effects of drug therapies on
the development of comorbid MDD in acne patients in the United States.
METHODS: A longitudinal retrospective study was conducted using the 2003-2007
MarketScan Medicaid Claims dataset representing 177,333 patients with acne vul-
garis. The Cox proportional-hazard survival analysis was performed to obtain the
hazard ratios (HRs) of MDD development, adjusting age, race, sex, physician spe-
cialty, Charlson Comorbidiy index (CCI), and acne drug treatment. RESULTS: Pa-
tients totalling 11,131 had an MDD occurrence within the study period. White
patients had the highest hazard of MDD incidence among all races (all p0.01).
Comparedwith adult patients, youths and childrenwere less likely to have anMDD
occurrence (HRs0.66 and 0.22, respectively; both p0.01). MDD was less frequent
in patients seen by dermatologists, family physicians, or pediatricians (all p0.01).
Patients whose acne was treated with isotretinoin, oral antibiotics, or topical anti-
biotics were less likely to have an MDD occurrence (HRs0.56, 0.41, and 0.46, re-
spectively; all p0.01). A unit of increase in CCI was associated with a 14% higher
hazard of MDD incidence (p0.01). CONCLUSIONS: The likelihood of MDD occur-
rence in acne patients treated with drug therapy varied with age and race. Consul-
tationwith dermatologists, family physicians, or pediatricianswas associatedwith
a lower hazard of MDD. Drug treatment of acne with isotretinoin, oral antibiotics,
or topical antibiotics was associatedwith a reduced incidence of secondaryMDD in
acne patients, indicating that the treatment of the primary cutaneous indication
may reduce the risk of secondary psychiatric comorbidities.
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COMPARISON OF RISK ADJUSTMENT METHODS IN PREDICTING HEALTH CARE
EXPENDITURE AMONG CHILDREN WITH ATTENTION DEFICIT/
HYPERACTIVITY DISORDER
Bali V, Johnson ML, Aparasu RR
University of Houston, Houston, TX, USA
OBJECTIVES: Pediatric Attention Deficit/Hyperactivity Disorder (ADHD) is associ-
ated with substantial financial burden on families, payers, and society. This study
compared different risk adjustmentmethods in predicting health care expenditure
among children with ADHD. METHODS: This study used data from 2008 Medical
Expenditure Panel Survey (MEPS) involving children from 5-17 years of age with
ADHD. Patients with ADHD were identified using International Classification of
Diseases, ninth revision, Clinical Modification (ICD-9-CM) code of ’314’. Diagnosis
based (D’Hoore version of Charlson comorbidity Index (CCI), Modified Elixhauser
comorbidity Index (MECI) ); pharmacy based (Chronic disease score-1 (CDS-1)); and
Columbia Impairment scale (CIS) were used to risk adjust total healthcare expen-
ditures. Performance of each of the comorbidity measures was compared after
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